Position in EXEL
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$4,070,792
+$672,618 QoQ
Shares Held
74,817
-5.6% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#193
of 754 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Crossmark Global Holdings, Inc. holds $48,601,060 across 36 Biotechnology names. EXEL ranks #3 (8.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
89,139 | $10,104,797 | |
| 2 | ARGX |
Argenx SE
|
9,684 | $8,984,524 | |
| 3 | EXEL |
Exelixis, Inc.
This page
|
74,817 | $4,070,792 | |
| 4 | ONC |
BeOne Medicines Ltd.
|
10,755 | $3,064,852 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
51,220 | $2,930,808 | |
| 6 | BNTX |
BioNTech SE
|
20,934 | $1,947,908 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
7,237 | $1,743,899 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,828 | $1,404,752 |
All Filings in EXEL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,070,792 | 74,817 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $3,398,174 | 79,230 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $3,480,102 | 79,400 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $3,274,140 | 79,277 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,054,790 | 23,929 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $834,724 | 22,609 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $751,080 | 22,555 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $587,896 | 22,655 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $509,753 | 22,686 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $1,307,712 | 55,108 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,419,919 | 59,188 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,133,577 | 51,880 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $560,954 | 29,354 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $582,163 | 29,993 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $489,155 | 30,496 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $481,062 | 30,680 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $646,460 | 31,050 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $709,796 | 31,310 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $557,722 | 30,510 | Shares | Sole | 2022-01-10 | |
| 2021-09-30 | $910,077 | 43,050 | Shares | Sole | 2021-10-21 | |
| 2021-06-30 | $785,099 | 43,090 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $955,331 | 42,290 | Shares | Sole | 2021-04-15 | |
| 2020-12-31 | $844,344 | 42,070 | Shares | Sole | 2021-01-14 | |
| 2020-09-30 | $900,004 | 36,810 | Shares | Sole | 2020-10-08 | |
| 2020-06-30 | $871,732 | 36,720 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $584,446 | 33,940 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||